Shandong Anxin Pharmaceutical
FDA Approved Drugs

Shandong Anxin Pharmaceutical

FDA Approved Drugs Database

FDA approved drug product records including application numbers, product numbers, drug names, active ingredients, dosage forms, strengths, approval dates and regulatory status.

RX
  • Total Records 4
  • Latest Approval Date Apr 14, 2023
  • Data Source FDA
  • First Approval Date Aug 10, 2018
Company Overview

Company

Shandong Anxin Pharmaceutical

Country

China

Website

Visit Website

Email

anxin@qilu-pharma.com

Social Profiles

Company Snapshot

Shandong Anxin Pharmaceutical

No. 10678, Wenliang Road, Dongjia Street, Licheng District, Jinan City, Shandong Province

China

en.qilu-anxin.com/ anxin@qilu-pharma.com View on Map
FDA Approved Drug Records ( 4 records )
2018
10 Aug
RX Application: 204959

Drug Name

PIPERACILLIN AND TAZOBACTAM

Product Number

1

Dosage Form

-

Strength

EQ 2GM BASE/VIAL;EQ 250MG BASE/VIAL

Approval Date

2018-08-10

204959 / 1

Active Ingredient

PIPERACILLIN SODIUM; TAZOBACTAM SODIUM

Application Number

204959

Product Number

1

Dosage Form

-

Strength

EQ 2GM BASE/VIAL;EQ 250MG BASE/VIAL

Approval Date

2018-08-10

Regulatory Status

RX

2018
10 Aug
RX Application: 204959

Drug Name

PIPERACILLIN AND TAZOBACTAM

Product Number

2

Dosage Form

-

Strength

EQ 3GM BASE/VIAL;EQ 375MG BASE/VIAL

Approval Date

2018-08-10

204959 / 2

Active Ingredient

PIPERACILLIN SODIUM; TAZOBACTAM SODIUM

Application Number

204959

Product Number

2

Dosage Form

-

Strength

EQ 3GM BASE/VIAL;EQ 375MG BASE/VIAL

Approval Date

2018-08-10

Regulatory Status

RX

2018
10 Aug
RX Application: 204959

Drug Name

PIPERACILLIN AND TAZOBACTAM

Product Number

3

Dosage Form

-

Strength

EQ 4GM BASE/VIAL;EQ 500MG BASE/VIAL

Approval Date

2018-08-10

204959 / 3

Active Ingredient

PIPERACILLIN SODIUM; TAZOBACTAM SODIUM

Application Number

204959

Product Number

3

Dosage Form

-

Strength

EQ 4GM BASE/VIAL;EQ 500MG BASE/VIAL

Approval Date

2018-08-10

Regulatory Status

RX

2023
14 Apr
RX Application: 217243

Drug Name

PIPERACILLIN AND TAZOBACTAM

Product Number

1

Dosage Form

-

Strength

EQ 36GM BASE/VIAL;EQ 4.5GM BASE/VIAL

Approval Date

2023-04-14

217243 / 1

Active Ingredient

PIPERACILLIN SODIUM; TAZOBACTAM SODIUM

Application Number

217243

Product Number

1

Dosage Form

-

Strength

EQ 36GM BASE/VIAL;EQ 4.5GM BASE/VIAL

Approval Date

2023-04-14

Regulatory Status

RX

Related Databases
  • FDA Inspections
    0 View
  • EDQM CEP
    7 View
  • KDMF
    0 View
  • Japan DMF
    0 View
  • Eudra GMP
    0 View
  • NDC Database
    0 View
  • FDA Approved Drugs Database
    4 View
  • Drug Prices in Switzerland
    0 View
Drug Status Breakdown
4 total
  • RX
Official Source

FDA approved drug data is based on publicly available U.S. Food and Drug Administration Orange Book information.

Visit FDA Orange Book
FDA Approved Drug Record Details Preview

Explore important FDA approved drug information available in the records above.

Drug Name

PIPERACILLIN AND TAZOBACTAM

Application Number

204959

Product Number

1

Active Ingredient

PIPERACILLIN SODIUM; TAZOBACTAM SODIUM

Dosage Form

-

Strength

EQ 2GM BASE/VIAL;EQ 250MG BASE/VIAL

FDA Approved Drug Data

Approved drug product information

Regular Updates

Data maintained from official sources

Structured Database

Searchable pharmaceutical data

Reliable Data

Organized FDA drug records

Create a New Buying Request

Fields marked with * are mandatory.

Please enter quantity.
Please select a unit.
Please select quality standard.
Please select request type.
Please provide product specifications.
Please enter additional details.
Please select shipping preference.
Notice: By submitting this buying request, the provided product details and requirements may be published publicly on our marketplace.
Login to Submit